Ems-Chemie Holding AG (EMSN.SW)
Domat/ems, CH
Ems-Chemie Holding AG is a global enterprise specializing in high-performance polymers and a diverse range of specialty chemical products. Its High Performance Polymers division focuses on the production and distribution of advanced polyamide granulates. The Specialty Chemicals sector innovates, manufactures, and markets a broad array of items, including various fibers, tire bonding agents, melt adhesives, and adhesive yarns designed for both industrial and textile uses. This segment also provides powder coatings and reactive diluents. Furthermore, the company's extensive product line encompasses comprehensive bonding, coating, sealing, and damping solutions, alongside hot-melt adhesives, cross-linking agents, epoxy systems, specialized technical fibers, adhesion-promoting substances, and fusible bonding yarns and granules. Ems-Chemie caters to a wide spectrum of industries, such as the automotive, electronics, industrial, consumer products, optics, and packaging sectors. Established in 1936, the company's headquarters are situated in Domat/Ems, Switzerland, and it operates as a subsidiary of EMESTA HOLDING AG.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.28% | +4.39% | +7.29% | +11.66% | +30.20% | +29.73% | +14.16% | +0.78% | -15.36% | +45.98% | +592.72% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 3 | -1 |
| Sell | 2 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +7.2%-5.8% Q4'25: -7.5% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +16.5%+1.4% Q4'25: +1.9% (vs Q4'23)
-
FCF margin Chemicals - Specialty: +27.4%+24.2% Q4'25: +34.6% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +9.5%+29.1% ★ Q4'25: +27.6% (vs Q4'23)
-
ROIC Chemicals - Specialty: +6.2%— Q4'25: +64.6% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.0%+0.0% Q4'25: -1.0% (vs Q4'23)
-
Debt / EBITDA Chemicals - Specialty: 0.21×0.00× ★ Q4'25: 0.03× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2000 actual |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 6 EPS Ana. |
Dec 2027 7 Rev. Ana. 6 EPS Ana. |
Dec 2028 5 Rev. Ana. 4 EPS Ana. |
Dec 2029 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.17B
est.
|
1.28B
est.
|
1.34B
est: 1.24B (+7.9%)
|
1.32B
est: 1.23B (+7.2%)
|
1.15B
est: 1.28B (-9.9%)
|
1.25B
est: 1.28B (-1.8%)
|
1.40B
est: 1.40B (-0.1%)
|
1.60B
est: 1.58B (+1.8%)
|
1.56B
est: 1.57B (-0.6%)
|
1.18B
est: 1.23B (-4.0%)
|
1.60B
est: 1.62B (-1.7%)
|
1.66B
est: 1.66B (+0.1%)
|
1.76B
est: 1.78B (-1.5%)
|
1.92B
est: 1.91B (+0.4%)
|
2.00B
est: 2.00B (+0.2%)
|
1.93B
est: 1.91B (+1.2%)
|
2.01B
est: 1.98B (+1.9%)
|
2.18B
est: 2.12B (+2.9%)
|
2.35B
est: 2.32B (+1.2%)
|
2.15B
est: 2.20B (-2.2%)
|
1.80B
est: 1.78B (+1.0%)
|
2.25B
est: 2.21B (+1.9%)
|
2.44B
est: 2.40B (+1.6%)
|
2.19B
est: 2.12B (+3.4%)
|
2.07B
est: 2.08B (-0.4%)
|
1.95B
est: 1.97B (-0.8%)
|
1.95B
1.90B – 2.01B
-0.6% YoY
|
2.02B
1.97B – 2.07B
+3.2% YoY
|
2.10B
2.10B – 2.11B
+4.2% YoY
|
2.18B
2.13B – 2.25B
+3.9% YoY
|
| EBITDA |
342.31M
est.
|
414.70M
est.
|
187.11M
est: 379.90M (-50.7%)
|
-75.41M
est: 294.33M (-125.6%)
|
257.69M
est: 347.80M (-25.9%)
|
325.24M
est: 313.20M (+3.8%)
|
295.97M
est: 320.75M (-7.7%)
|
518.16M
est: 594.20M (-12.8%)
|
383.14M
est: 440.67M (-13.1%)
|
319.47M
est: 244.16M (+30.8%)
|
362.48M
est: 396.24M (-8.5%)
|
350.24M
est: 334.27M (+4.8%)
|
378.64M
est: 371.13M (+2.0%)
|
416.60M
est: 393.30M (+5.9%)
|
470.68M
est: 472.45M (-0.4%)
|
512.81M
est: 442.73M (+15.8%)
|
599.36M
est: 519.05M (+15.5%)
|
637.35M
est: 628.24M (+1.4%)
|
672.73M
est: 696.38M (-3.4%)
|
674.62M
est: 631.49M (+6.8%)
|
566.20M
est: 540.95M (+4.7%)
|
698.03M
est: 623.37M (+12.0%)
|
658.40M
est: 643.32M (+2.3%)
|
542.36M
est: 687.61M (-21.1%)
|
603.52M
est: 677.26M (-10.9%)
|
608.65M
est: 638.49M (-4.7%)
|
634.94M
618.63M – 653.01M
-0.6% YoY
|
655.44M
639.46M – 673.32M
+3.2% YoY
|
683.24M
681.58M – 684.90M
+4.2% YoY
|
709.58M
691.82M – 729.35M
+3.9% YoY
|
| EBIT |
212.13M
est.
|
234.50M
est.
|
120.61M
est: 154.29M (-21.8%)
|
-143.78M
est: 198.31M (-172.5%)
|
270.88M
est: 5.79M (+4,581.3%)
|
268.40M
est: 158.80M (+69.0%)
|
549.90M
est: 236.97M (+132.1%)
|
464.80M
est: 278.53M (+66.9%)
|
324.94M
est: 268.90M (+20.8%)
|
261.68M
est: 171.90M (+52.2%)
|
309.02M
est: 294.23M (+5.0%)
|
298.24M
est: 286.81M (+4.0%)
|
324.33M
est: 316.45M (+2.5%)
|
387.14M
est: 341.71M (+13.3%)
|
417.39M
est: 385.68M (+8.2%)
|
459.56M
est: 410.50M (+12.0%)
|
543.08M
est: 485.15M (+11.9%)
|
583.71M
est: 585.90M (-0.4%)
|
618.98M
est: 638.74M (-3.1%)
|
621.09M
est: 587.01M (+5.8%)
|
511.39M
est: 506.91M (+0.9%)
|
642.02M
est: 584.15M (+9.9%)
|
607.30M
est: 602.84M (+0.7%)
|
492.73M
est: 615.21M (-19.9%)
|
550.16M
est: 605.95M (-9.2%)
|
553.38M
est: 571.27M (-3.1%)
|
568.09M
553.49M – 584.25M
-0.6% YoY
|
586.43M
572.13M – 602.43M
+3.2% YoY
|
611.30M
609.82M – 612.79M
+4.2% YoY
|
634.87M
618.98M – 652.56M
+3.9% YoY
|
| Net Income |
223.54M
est.
|
278.34M
est.
|
164.90M
est: 170.12M (-3.1%)
|
113.35M
est: 160.26M (-29.3%)
|
183.43M
est: 110.46M (+66.1%)
|
177.13M
est: 152.40M (+16.2%)
|
297.44M
est: 193.94M (+53.4%)
|
293.75M
est: 335.64M (-12.5%)
|
215.21M
est: 281.94M (-23.7%)
|
221.22M
est: 165.80M (+33.4%)
|
232.10M
est: 286.66M (-19.0%)
|
242.15M
est: 230.08M (+5.2%)
|
267.02M
est: 255.21M (+4.6%)
|
317.62M
est: 286.37M (+10.9%)
|
342.87M
est: 332.04M (+3.3%)
|
376.25M
est: 332.55M (+13.1%)
|
448.76M
est: 389.54M (+15.2%)
|
481.51M
est: 480.05M (+0.3%)
|
519.62M
est: 528.47M (-1.7%)
|
527.14M
est: 491.84M (+7.2%)
|
434.34M
est: 428.41M (+1.4%)
|
550.32M
est: 493.69M (+11.5%)
|
532.10M
est: 492.10M (+8.1%)
|
457.58M
est: 461.53M (-0.9%)
|
460.79M
est: 461.84M (-0.2%)
|
467.00M
est: 466.51M (+0.1%)
|
490.50M
461.05M – 504.66M
+5.1% YoY
|
511.66M
492.56M – 537.02M
+4.3% YoY
|
534.57M
507.27M – 557.01M
+4.5% YoY
|
536.65M
519.19M – 556.09M
+0.4% YoY
|
| SGA |
372.93M
est.
|
378.35M
est.
|
263.45M
est: 354.33M (-25.6%)
|
266.17M
est: 442.83M (-39.9%)
|
38.26M
est: 415.58M (-90.8%)
|
35.68M
est: 354.63M (-89.9%)
|
56.37M
est: 284.28M (-80.2%)
|
—
est: 306.07M (-100.0%)
|
—
est: 220.54M (-100.0%)
|
—
est: 169.32M (-100.0%)
|
—
est: 258.94M (-100.0%)
|
—
est: 317.26M (-100.0%)
|
32.78M
est: 325.71M (-89.9%)
|
232.07M
est: 333.56M (-30.4%)
|
256.13M
est: 340.72M (-24.8%)
|
232.06M
est: 344.06M (-32.6%)
|
238.24M
est: 335.37M (-29.0%)
|
233.64M
est: 363.89M (-35.8%)
|
253.70M
est: 370.37M (-31.5%)
|
59.46M
est: 345.53M (-82.8%)
|
48.46M
est: 280.75M (-82.7%)
|
51.21M
est: 323.52M (-84.2%)
|
64.50M
est: 333.88M (-80.7%)
|
61.72M
est: 53.34M (+15.7%)
|
32.82M
est: 52.54M (-37.5%)
|
64.00M
est: 49.53M (+29.2%)
|
49.25M
47.99M – 50.66M
-0.6% YoY
|
50.85M
49.61M – 52.23M
+3.2% YoY
|
53.00M
52.87M – 53.13M
+4.2% YoY
|
55.04M
53.67M – 56.58M
+3.9% YoY
|
| EPS |
8.65
est.
|
7.57
est.
|
6.17
est: 6.85 (-10.0%)
|
4.10
est: 6.17 (-33.5%)
|
7.33
est: 7.27 (+0.8%)
|
7.30
est: 7.35 (-0.7%)
|
12.99
est: 9.95 (+30.5%)
|
12.14
est: 9.89 (+22.8%)
|
9.25
est: 8.12 (+13.9%)
|
9.66
est: 7.46 (+29.6%)
|
9.71
est: 9.95 (-2.4%)
|
10.14
est: 9.89 (+2.5%)
|
11.45
est: 11.19 (+2.3%)
|
13.58
est: 13.17 (+3.1%)
|
14.66
est: 15.53 (-5.6%)
|
16.09
est: 15.25 (+5.5%)
|
19.19
est: 17.96 (+6.8%)
|
20.59
est: 20.00 (+2.9%)
|
22.22
est: 21.80 (+1.9%)
|
22.54
est: 22.18 (+1.6%)
|
18.57
est: 18.20 (+2.0%)
|
23.53
est: 23.12 (+1.8%)
|
22.75
est: 22.48 (+1.2%)
|
19.56
est: 19.73 (-0.9%)
|
19.70
est: 19.43 (+1.4%)
|
19.97
est: 20.25 (-1.4%)
|
20.91
19.71 – 21.58
+3.3% YoY
|
21.95
21.06 – 22.96
+4.9% YoY
|
23.03
21.69 – 23.82
+4.9% YoY
|
22.94
22.20 – 23.78
-0.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-05 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-04 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-14 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-13 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-10 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Alexander Hergert | Chief Financial Officer & Member of Executive Management | — | — |
| Magdalena Martullo-Blocher | Vice-Chairman, Chief Executive Officer & Member of Executive Management | — | female |
| Urs Janssen | Member of Executive Management | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EMSN.SW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
